abrdn World Healthcare Fund Shares of Beneficial Interest (THW)

FairStock Score: 42/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a value investor, I start by asking what this thing really is. abrdn World Healthcare Fund is a closed-end fund, not an operating business; it owns healthcare equities and corporate debt, so its fate depends on the portfolio manager and the underlying markets. There is no conventional competitive moat—no brand or pricing power—only the mandate and the manager's ability. The provided figures show a $492.8 million market cap, a price of $11.94 at the close on 2026-10-13, and a 52-week range of $11.18 to $14.50. FairStock's calculations show a P/E of 5.61, a Graham Number of $23.89, and a 50.02% margin of safety, which superficially looks cheap. The dividend yield is 11.06%, which is attractive but also demands scrutiny. The weak spots are serious: Piotroski F-Score is 0/9, Altman Z-Score is 2.48, and the Lynch category is none because there are only 0 years of filed results—three are needed. Revenue growth, profit growth, ROE, ROCE, and debt data are unavailable, so I cannot underwrite the growth trajectory. The FairStock Score of 42/100 suggests the quantitative picture is not strong. For a fund, the true valuation test is net asset value and the discount or premium to it, which I do not have here. Graham would insist on a margin of safety, but he would also demand reliable history. With no filed results and weak financial-health signals, the low P/E and high yield could be value traps unless the portfolio and distribution are well covered. I would watch NAV, distribution coverage, and healthcare/credit conditions closely.

In plain English: This closed-end fund invests in healthcare company stocks along with some corporate bonds. Its business looks mixed: the price is near the low end of its 52-week range and appears inexpensive on a few valuation checks, but other financial-health signals are weak and there is very little filed history to judge. At $11.94, it looks cheap on those checks, though the high income it pays adds risk.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer